Active surveillance for prostate cancer: an update

An increasing number of men diagnosed with localised prostate cancer has been accompanied by more men being considered for active surveillance as a management option. Here the author provides an update on recent developments in active surveillance and changes to NICE guidance.
Source: Trends in Urology and Men's Health - Category: Urology & Nephrology Authors: Tags: Prostate disease Source Type: research

Related Links:

Condition:   Metastatic Castration-Resistant Prostate Cancer Interventions:   Drug: Lu-PSMA;   Drug: Enzalutamide Sponsors:   Australian and New Zealand Urogenital and Prostate Cancer Trials Group;   National Health and Medical Research Council, Clinical Trials Centre;   Prostate Cancer Research Alliance;   Endocyte;   Astellas Pharma Inc;   Australian Nuclear Science and Technology Organisation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: Circular RNA_LARP4 could suppress cell migration and invasion of PCa by upregulating FOXO3A. PMID: 32495863 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
In order to limit radiotherapy (RT)-related side effects, effective toxicity prediction and assessment schemes are essential. In recent years, the growing interest toward artificial intelligence and machine learning (ML) within the science community has led to the implementation of innovative tools in RT. Several researchers have demonstrated the high performance of ML-based models in predicting toxicity, but the application of these approaches in clinics is still lagging, partly due to their low interpretability. Therefore, an overview of contemporary research is needed in order to familiarize practitioners with common me...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Metastatic prostate cancer is incurable, and novel methods to detect the disease earlier and to direct definitive treatment are needed. Molecularly specific tools to localize diagnostic and cytotoxic radionuclide payloads to cancer cells and the surrounding microenvironment are recognized as a critical component of new approaches to combat this disease. The implementation of theranostic approaches to characterize and personalize patient management is beginning to be realized for prostate cancer patients. This review article summarized clinically translated approaches to detect, characterize, and treat disease in this rapidly expanding field.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
ConclusionsMaximal reduction of the rectal dose seems very important to prevent serious rectal hemorrhage. In addition, we should consider the risk of rectal toxicities in patients with abnormalities in the rectal mucosa, especially hemorrhoids.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
AbstractPurposeRobot-assisted laparoscopic radical prostatectomy (RALRP) using the da Vinci surgical robot is a common treatment for organ-confined prostate cancer. Augmented reality (AR) can help during RALRP by showing the surgeon the location of anatomical structures and tumors from preoperative imaging. Previously, we proposed hand-eye and camera intrinsic matrix estimation procedures that can be carried out with conventional instruments within the patient during surgery, take
Source: International Journal of Computer Assisted Radiology and Surgery - Category: Intensive Care Source Type: research
AbstractThere is growing evidence that MRI-ultrasound (MR-US)-targeted biopsy (TB) has high detection rates of clinically significant prostate cancer (PCa) compared to standard transrectal ultrasound (TRUS)-guided biopsy. A radiologist plays a significant role in MR-US fusion biopsy planning. Here, we discuss six simple steps that can help set up a successful MR-US fusion biopsy program in collaboration with the urologist.
Source: Abdominal Imaging - Category: Radiology Source Type: research
Publication date: Available online 3 June 2020Source: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of LipidsAuthor(s): Maciej Roman, Tomasz P. Wrobel, Agnieszka Panek, Czeslawa Paluszkiewicz, Wojciech M. Kwiatek
Source: Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids - Category: Lipidology Source Type: research
Publication date: Available online 3 June 2020Source: Saudi Journal of Biological SciencesAuthor(s): Xiaoming Wang, Bo Wang, Liquan Zhou, Xiang Wang, Vishnu Priya Veeraraghavan, Surapaneni Krishna Mohan, Feng Xin
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
The objective of this work was to identify the risk factors (RFs) of active surveillance (AS) interruption in a prostate cancer (PCa) single-center retrospective cohort of patients. MATERIAL AND METHOD: All patients in AS between January 2011 and October 2019 were retrospectively included in a computerized database. The group of patients who had an AS interruption was compared to the one still under AS, in order to identify potential risk factors for the interruption of the surveillance protocol. RESULTS: Two hundred and two patients have been included in the AS cohort with a median follow-up of 32months. At the ti...
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Cancer | Cancer & Oncology | National Institute for Health and Clinical Excelle | Prostate Cancer | Urology & Nephrology